WhitTier Trust Company’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$242K Sell
544
-8
-1% -$3.56K 0.01% 497
2025
Q1
$268K Buy
552
+67
+14% +$32.5K 0.01% 481
2024
Q4
$195K Sell
485
-91
-16% -$36.6K ﹤0.01% 499
2024
Q3
$268K Buy
576
+25
+5% +$11.6K 0.01% 439
2024
Q2
$258K Sell
551
-28
-5% -$13.1K 0.01% 434
2024
Q1
$242K Buy
579
+18
+3% +$7.52K 0.01% 442
2023
Q4
$228K Sell
561
-301
-35% -$122K 0.01% 443
2023
Q3
$300K Sell
862
-5
-0.6% -$1.74K 0.01% 394
2023
Q2
$305K Sell
867
-4
-0.5% -$1.41K 0.01% 405
2023
Q1
$274K Buy
871
+373
+75% +$118K 0.01% 414
2022
Q4
$144K Sell
498
-340
-41% -$98.2K 0.01% 496
2022
Q3
$243K Buy
838
+315
+60% +$91.3K 0.01% 433
2022
Q2
$147K Sell
523
-96
-16% -$27K 0.01% 499
2022
Q1
$162K Hold
619
0.01% 490
2021
Q4
$136K Sell
619
-32
-5% -$7.03K 0.01% 520
2021
Q3
$118K Buy
651
+366
+128% +$66.3K ﹤0.01% 525
2021
Q2
$57K Hold
285
﹤0.01% 640
2021
Q1
$61K Hold
285
﹤0.01% 608
2020
Q4
$67K Hold
285
﹤0.01% 575
2020
Q3
$78K Hold
285
﹤0.01% 538
2020
Q2
$83K Hold
285
0.01% 507
2020
Q1
$68K Hold
285
0.01% 516
2019
Q4
$62K Hold
285
﹤0.01% 558
2019
Q3
$48K Hold
285
﹤0.01% 605
2019
Q2
$52K Hold
285
﹤0.01% 580
2019
Q1
$52K Hold
285
﹤0.01% 581
2018
Q4
$47K Hold
285
﹤0.01% 584
2018
Q3
$55K Hold
285
﹤0.01% 598
2018
Q2
$48K Hold
285
﹤0.01% 613
2018
Q1
$46K Hold
285
﹤0.01% 626
2017
Q4
$43K Hold
285
﹤0.01% 595
2017
Q3
$43K Hold
285
﹤0.01% 566
2017
Q2
$37K Hold
285
﹤0.01% 593
2017
Q1
$31K Hold
285
﹤0.01% 618
2016
Q4
$21K Hold
285
﹤0.01% 684
2016
Q3
$25K Sell
285
-40
-12% -$3.51K ﹤0.01% 652
2016
Q2
$28K Buy
325
+40
+14% +$3.45K ﹤0.01% 620
2016
Q1
$23K Hold
285
﹤0.01% 663
2015
Q4
$36K Hold
285
﹤0.01% 579
2015
Q3
$30K Hold
285
﹤0.01% 610
2015
Q2
$35K Hold
285
﹤0.01% 598
2015
Q1
$34K Hold
285
﹤0.01% 603
2014
Q4
$34K Hold
285
﹤0.01% 600
2014
Q3
$32K Hold
285
﹤0.01% 614
2014
Q2
$27K Hold
285
﹤0.01% 658
2014
Q1
$20K Hold
285
﹤0.01% 738
2013
Q4
$21K Hold
285
﹤0.01% 680
2013
Q3
$22K Hold
285
﹤0.01% 645
2013
Q2
$23K Buy
+285
New +$23K ﹤0.01% 614